Biotechnology, Medical, Therapeutics
TRIMTECH Therapeutics
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
Seed · $14M · 106d agotrimtechtherapeutics.com
Hiring velocity
- Open roles
- 0
- Added, 30 days
- +0
- Added, 7 days
- +0
- Closed, 30 days
- 2
- Raised
- 106 days ago
- Led by
- Eli Lilly, Business Growth Fund, Cambridge Innovation Capital, Dementia Discovery Fund, Johnson & Johnson Innovation
- Team size
- 1-10
- HQ
- Cambridge, Massachusetts, United States
- Tracked since
- Oct 4, 2026
Open roles at TRIMTECH Therapeutics
Source: trimtechtherapeutics.com, checked daily.